{"DataElement":{"publicId":"2007719","version":"1","preferredName":"Disease Involvement Type","preferredDefinition":"the type or extent of the patient's disease.","longName":"DZ_INVLT_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014865","version":"1","preferredName":"Disease Involvement","preferredDefinition":"involvement by the patient's disease.","longName":"DZ_INVLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177151","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A disease is any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. (from Wikipedia)","longName":"Disease","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A50-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Updated to add EVS concept preferred name. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177473","version":"1","preferredName":"Involvement","preferredDefinition":"Involvement; a connection by participation or association or use.","longName":"Involvement","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5222-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C33AD1B9-9F83-2076-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance and released","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019131","version":"1","preferredName":"Disease Involvement Type","preferredDefinition":"the type of disease involvement of a particular anatomic site.","longName":"DZ_INVLT_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"90","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Recurrence/progressive disease in originally involved site","valueDescription":"Recurrence/progressive disease in originally involved site","ValueMeaning":{"publicId":"2566907","version":"1","preferredName":"Recurrence/progressive disease in originally involved site","longName":"2566907","preferredDefinition":"Recurrence/progressive disease in originally involved site","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D268-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-08-28","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5F84DFB-AB65-1002-E034-0003BA12F5E7","beginDate":"2003-08-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-08-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Recurrence/progressive disease","valueDescription":"Recurrence/progressive disease","ValueMeaning":{"publicId":"2566282","version":"1","preferredName":"Recurrence/progressive disease","longName":"2566282","preferredDefinition":"Recurrence/progressive disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFF7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C33ADEF6-E7BD-2082-E034-0003BA12F5E7","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"New tumor/lesion site","valueDescription":"New tumor/lesion site","ValueMeaning":{"publicId":"2566281","version":"1","preferredName":"New tumor/lesion site","longName":"2566281","preferredDefinition":"New tumor/lesion site","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFF6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C33ADEF6-E7C0-2082-E034-0003BA12F5E7","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Existing/non-progressive tumor","valueDescription":"Existing/non-progressive tumor","ValueMeaning":{"publicId":"2566280","version":"1","preferredName":"Existing/non-progressive tumor","longName":"2566280","preferredDefinition":"Existing/non-progressive tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFF5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C33ADEF6-E7C3-2082-E034-0003BA12F5E7","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Uninvolved","valueDescription":"Uninvolved","ValueMeaning":{"publicId":"2566279","version":"1","preferredName":"Uninvolved","longName":"2566279","preferredDefinition":"Uninvolved","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C33ADEF6-E7C6-2082-E034-0003BA12F5E7","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Locally advanced","valueDescription":"Locally advanced","ValueMeaning":{"publicId":"2574344","version":"1","preferredName":"Locally advanced","longName":"2574344","preferredDefinition":"To a restricted area (of the body).: Far along in course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Locally","conceptCode":"C41065","definition":"To a restricted area (of the body).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Advanced","conceptCode":"C25411","definition":"Far along in course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF75-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-07","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7472988E-D10F-00A0-E040-BB89AD433FCF","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":"Metastatic","ValueMeaning":{"publicId":"2574077","version":"1","preferredName":"Metastatic","longName":"2574077","preferredDefinition":"Metastatic","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-29","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7472988E-D119-00A0-E040-BB89AD433FCF","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"},{"value":"Breast cancer, NOS","valueDescription":"Breast Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3232681","version":"1","preferredName":"Breast Carcinoma Not Otherwise Specified","longName":"3232681","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A24EC569-9B30-677A-E040-BB89AD433E0A","latestVersionIndicator":"Yes","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A24EC569-9B49-677A-E040-BB89AD433E0A","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"ONEDATA","dateModified":"2011-05-02","deletedIndicator":"No"},{"value":"Invasive breast carcinoma","valueDescription":"Invasive Breast Carcinoma","ValueMeaning":{"publicId":"2581143","version":"1","preferredName":"Invasive Breast Carcinoma","longName":"2581143","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma. The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU). Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ. It is the most common carcinoma affecting women. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A04-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A24EC569-9B5D-677A-E040-BB89AD433E0A","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"ONEDATA","dateModified":"2011-05-02","deletedIndicator":"No"},{"value":"Adenocarcinoma of the rectum","valueDescription":"Adenocarcinoma Rectum","ValueMeaning":{"publicId":"3232682","version":"1","preferredName":"Adenocarcinoma Rectum","longName":"3232682","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rectum","conceptCode":"C12390","definition":"The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A24EC569-9B6A-677A-E040-BB89AD433E0A","latestVersionIndicator":"Yes","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A24EC569-9B83-677A-E040-BB89AD433E0A","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"ONEDATA","dateModified":"2011-05-02","deletedIndicator":"No"},{"value":"Colorectal cancer, NOS","valueDescription":"Colorectal Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3232683","version":"1","preferredName":"Colorectal Carcinoma Not Otherwise Specified","longName":"3232683","preferredDefinition":"A carcinoma arising from the colon or rectum. Among both males and females, it is the second most common visceral malignancy in the United States, with an expected 185,000 new cases each year. It is considered as a disease of Western-world lifestyle. Grossly, most colorectal carcinomas are either polypoid or of the ulcerative-infiltrating type. Adenocarcinoma is the most common carcinoma in the colon and rectum. Colorectal adenocarcinoma can be divided in three grades: Grade I (low grade or well-differentiated), grade II (average grade or moderately differentiated) and grade III (poorly differentiated). The following histopathologic features have been shown to be prognostic indicators in multivariate analysis: microacinar versus macroacinar growth pattern, endocrine cells detected by chromogranin immunohistochemistry, Crohn's-like reaction and tumor budding. The standard therapy for colorectal carcinoma is surgical resection. The 5-year crude survival rate after curative resection for colorectal carcinomas ranges between 40% and 60% in most large series (Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999).: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Carcinoma","conceptCode":"C2955","definition":"A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A24EC569-9B90-677A-E040-BB89AD433E0A","latestVersionIndicator":"Yes","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A24EC569-9BA9-677A-E040-BB89AD433E0A","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"ONEDATA","dateModified":"2011-05-02","deletedIndicator":"No"},{"value":"Adenocarcinoma of the colon","valueDescription":"Adenocarcinoma Colon","ValueMeaning":{"publicId":"3232684","version":"1","preferredName":"Adenocarcinoma Colon","longName":"3232684","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Colon","conceptCode":"C12382","definition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A24EC569-9BB6-677A-E040-BB89AD433E0A","latestVersionIndicator":"Yes","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A24EC569-9BCF-677A-E040-BB89AD433E0A","beginDate":"2011-05-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-02","modifiedBy":"ONEDATA","dateModified":"2011-05-02","deletedIndicator":"No"},{"value":"Locally recurrent","valueDescription":"Locally Recurrent Disease","ValueMeaning":{"publicId":"5041676","version":"1","preferredName":"Locally Recurrent Disease","longName":"5041676","preferredDefinition":"Restricted to the site of origin, without evidence of spread.: The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized","conceptCode":"C14146","definition":"Restricted to the site of origin, without evidence of spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23574F9B-85B5-10FE-E050-BB89AD434AF1","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23574F9B-85CE-10FE-E050-BB89AD434AF1","beginDate":"2015-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C33ACCC4-AED9-1FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"REEVESD","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"3298577","version":"1","longName":"Hepatobiliary","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Type of Involvement","type":"Preferred Question Text","description":"Type of Involvement","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Extent of disease","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Patient's simplified disease code","url":null,"context":"CTEP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Extent of disease at time of treatment with the ER agent.","url":null,"context":"CTEP"},{"name":"CCR Question Text","type":"Alternate Question Text","description":"Cancer disease stage","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C33AD297-57D5-2084-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-24","modifiedBy":"COOPERM","dateModified":"2020-06-12","changeDescription":"12/11/14 jc added Exceptional Responder CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}